Please wait...
About This Project
Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections are in urgent demand across the entire world as the Coronavirus Disease 2019 (COVID-19) pandemic continues to interrupt the well-being of human life. Without clinical therapeutics available for any of the human coronaviruses, a key starting point is to focus on target-based high-throughput screening (HTS) to reveal potent anti-SARS-CoV-2 hit-to-leads that are safe to human cells.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Working towards a low-cost ostomy bag that doesn't leak
Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...
A robust and clinical-friendly CRISPR diagnostic test kit for rapid SARS-COV2 detection
The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of...